Detalhe da pesquisa
1.
RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes.
Diabet Med
; 35(1): 33-40, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044772
2.
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline.
Diabetes Obes Metab
; 17(4): 403-13, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25580570
3.
Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.
Diabetes Obes Metab
; 17(9): 887-95, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26095087
4.
A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice.
Diabetologia
; 56(6): 1417-24, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23503814
5.
Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
Int J Obes (Lond)
; 37(5): 678-84, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22665137
6.
Peptides originally derived from Chilobrachys jingzhao tarantula venom possess beneficial effects on pancreatic beta cell health and function.
Eur J Pharmacol
; 954: 175855, 2023 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391009
7.
A novel peptide isolated from Aphonopelma chalcodes tarantula venom with benefits on pancreatic islet function and appetite control.
Biochem Pharmacol
; 212: 115544, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37044298
8.
Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain.
J Neurosci Res
; 89(4): 481-9, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21312223
9.
Comparison of independent and combined effects of the neurotensin receptor agonist, JMV-449, and incretin mimetics on pancreatic islet function, glucose homeostasis and appetite control.
Biochim Biophys Acta Gen Subj
; 1865(8): 129917, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964357
10.
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet.
Int J Obes (Lond)
; 34(8): 1341-4, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20351729
11.
Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance.
Diabetes Obes Metab
; 12(10): 891-9, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20920042
12.
A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice.
Biochem Pharmacol
; 171: 113723, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756326
13.
Effect of RU486 on hepatic and adipocyte gene expression improves diabetes control in obesity-type 2 diabetes.
Horm Metab Res
; 41(12): 899-904, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19670152
14.
Effects of an enzymatically stable C-terminal hexapseudopeptide fragment peptide of xenin-25, ψ-xenin-6, on pancreatic islet function and metabolism.
Mol Cell Endocrinol
; 496: 110523, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31352038
15.
Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice.
Eur J Pharmacol
; 865: 172733, 2019 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31614140
16.
Characterisation of Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonists in Rodent Pancreatic Beta Cells and Mice.
Clin Med Insights Endocrinol Diabetes
; 12: 1179551419875453, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31548798
17.
Daily administration of the GIP-R antagonist (Pro3)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti-obesity-diabetes actions of (Pro3)GIP.
Diabetes Obes Metab
; 10(4): 336-42, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18333892
18.
Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential.
Biochem Pharmacol
; 155: 264-274, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028989
19.
Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
J Endocrinol
; 191(1): 93-100, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17065392
20.
Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice.
Mol Cell Endocrinol
; 420: 37-45, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26607806